DVA · 10-Q · 2026Q2 · Full report
Revenue Recognition and Contract Assets
DAVITA INC. · 2026-08-04 · Importance 46 · Surprise 56 · In source text
DaVita recognized $98.5 million of integrated kidney care revenue for performance obligations satisfied in previous years during the six months ended June 30, 2026, up from $95.9 million in the prior-year period. Customer contract assets increased 28.6% to $399.2 million at June 30, 2026, from $310.5 million at December 31, 2025. Measurement limitations and recognition constraints affected value-based care contracts with health plans and the government Comprehensive Kidney Care Contracting program for plan years 2025 and 2026. The increase in contract assets indicates that a larger amount of earned or estimated consideration remained subject to future billing or collection resolution.
Key facts
- Accounts receivable as of June 30, 2026: $2,467,056 source
- U.S. dialysis accounts receivable at June 30, 2026: $1.719 billion, representing approximately 52 days of revenue outstanding (DSO) source
- Carrying value of customer contract assets as of June 30, 2026: $399,165 and as of December 31, 2025: $310,541 source
- Contract assets and other receivables as of June 30, 2026: $565,566 source
- U.S. dialysis accounts receivable at December 31, 2025: $1.610 billion, representing approximately 49 days of revenue outstanding (DSO) source
- Increase in DSO primarily due to timing of collections source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| assets | positive | realized | — | Accounts receivable as of June 30, 2026: $2,467,056 |
| assets | unclear | realized | — | U.S. dialysis accounts receivable at June 30, 2026: $1.719 billion, representing approximately 52 days of revenue outstanding (DSO) |